Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
- Latest Posts
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
Best in Biotech 14 Nov 2024
8 biotech companies advancing new treatments for breast cancer in 2024
Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments.
In Depth 13 Nov 2024
Sleep apnea: biotechs snore points in the therapeutic space
Therapeutic strides in biotech are proving to help address different stages of the sleep apnea.
Best in Biotech 12 Nov 2024
Six exosome therapy companies driving development in the field
Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.
Unlocking consistency in ATMP development: How cryopreservation strengthens Europe’s cell therapy supply chain
Discover how innovative cell therapy cryopreservation solutions are strengthening Europe’s ATMP supply chain.
ADVERTISEMENT
ADVERTISEMENT
In Depth 11 Nov 2024
Gene editing sector investment struggles: What’s driving the slowdown?
Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs.
Expert Advice 8 Nov 2024
How to negotiate your job offer in biotech
Learn how to be prepared to negotiate your biotech job offer by reading the tips that experts shared with us.
Podcast 8 Nov 2024
How to succeed as a woman in biotech
This week, with Kate Yen, CEO of Auron Therapeutics, we talk about women working as CEOs, or other senior roles, in the biotech space.
In Depth 7 Nov 2024
The biggest private biotech investments in October 2024
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.
Best in Biotech 7 Nov 2024
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease.
In Depth 6 Nov 2024
Tuberculosis research: Are we finally close to developing a more effective treatment option?
Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options.
ADVERTISEMENT
